Local recommendations (Nervous system)

For DMARD Shared Care click here

Antidepressants

Recommendation Approval date Review date
Specialist Initiated Drugs Prescribing Information Sheet Bupropion EKPG May 2018 May 2021
Patient information - changes to Trimipramine prescribing   April 2021
Trimipramine Audit - Patient information about reducing dose   April 2021
Trimipramine Audit - Patient information about switching to Sertraline   April 2021
Trimipramine Audit - Patient information about switching to Imipramine   April 2021
Trimipramine PrescQIPP Information   April 2021
Trimipramine briefing   April 2021
East Kent CCGs Protocol for the Management of Long Term Mental Health Conditions in Primary Care   April 2021
Vortioxetine Prescribing Guidelines - Feb 2019 Feb 2019 Feb 2022
Agomelatine Prescribing Guidelines May 2019 May 2022
Depression guidelines for primary care April 2019 April 2022

Anxiolytics, hypnotics and sedatives

Recommendation Approval date Review date
Benzodiazepine and Z-hypnotic prescribing policy June 2012 April 2021
PR 2021-10: Melatonin for sleep disorders in children with neurodevelopmental disorders August 2021 August 2022
Chloral Hydrate in Children and Young People with Movement and Motor Disorders April 2022 April 2024
Kent and Medway Melatonin Guidance December 2023 December 2025
Melatonin Prescribing Checklist for Clinicians
April 2024 April 2026

Adult ADHD Prescribing

Recommendation Approval date Review date
Adult ADHD Shared Care December 2023 December 2025

Dementia

Recommendation Approval date Review date
BPSD Guidance for GPs March 2022 March 2024
K&M Dementia Medication Prescribing Guidance October 2023 October 2025

Epilepsy

Recommendation Approval date Review date
Brivaracetam Information Sheet December 2021 December 2023
Buccal Midazolam for Patients with Epilepsy - EKPG Recommendation June 2018 June 2021
Eslicarbazepine Prescribing Guidelines - EKPG September 2014 April 2021
Lacosamide Prescribing Guidelines - EKPG September 2014 April 2021
Zonisamide Prescribing Guidelines - EKPG September 2014 April 2021
Kent and Medway Perampanel Prescribing Guidance August 2022 August 2024
Cenobamate Prescribing v1.3 August 2022 August 2024

Movement disorders - Dystonias and Parkinson's Disease

Recommendation Approval date Review date
Botulinum toxin for masseteric hypertrophy, EKPG Recommendation June 2016 April 2021
Botulinum toxin for spasticity in adults, EKPG Recommendation July 2016 April 2021
Botulinum toxin type A for blepharospasm EKPG Recommendation June 2015 April 2021
Botulinum toxin type A for facial lines EKPG Recommendation March 2016 April 2021
EKPG Recommendation, Botulinum Toxin for Frey's syndrome May 2016 April 2021
EKPG Recommendation for Botulinum toxin for sialorrhoea in adults September 2016 April 2021
Shared Care Guideline Riluzole May 2018 May 2021
Co-careldopa intestinal gel (Duodopa) for the treatment of advanced Parkinsons disease EKPG October 2013 April 2021
Kent and Medway PRGC Policy Recommendation. Botulinum neurotoxin (BoNT) for the management of cervical dystonias and hemifacial spasms in adults PR 2021-22 April 2022 April 2024

Cannabis based medicinal products

Recommendation Approval date Review date
Cannabis-based-medication-desk-guide November 2018 November 2021

Pain

Recommendation Approval date Review date
Pain medication guidelines FINAL1   April 2021
East Kent Algorithm 3   April 2021
00929 - Constipation v21   April 2021
Tramadol-Marol Modified Release Caps&Tabs Recommendations, EKPG December 2013 April 2021
B194. Co-proxamol 2.0 January 2018 April 2021
KMCCG Lidocaine plaster position statement September 2021 September 2023
Opioid Tapering Resource Pack April 2022 April 2024
KMCCG Opioid Position Statement on Opioid Prescribing  April 2022 April 2024
KM Controlled Drugs Benzo Treatment Agreement April 2022 April 2024
Kent and Medway Guidance to Support the Safe and Effective, Initiation and Review of Opioids February 2023 February 2025
Information leaflet – 10 opioid safety messages February 2023 February 2025
Kent and Medway Position Statement: Safe Prescribing of Injectable Medicines in Primary Care October 2023 October 2025
Morphine Liquid Appropriate Use Guidance October 2023 October 2025
Prescribing Liquid Morphine Position Statement October 2023 October 2025
Actimorph Patient Leaflet December 2023 December 2025

Psychoses and related disorders

Recommendation Approval date Review date
Quetiapine Prescribing Guidelines February 2015 April 2021
Minimum Physical Health Monitoring Requirements for Commonly Prescribed Psychotropic Medications February 2017 February 2020
Lithium Treatment Pathway December 2022 December 2024

Sleep disorders

Recommendation Approval date Review date
Sodium oxybate for the treatment of narcolepsy with cataplexy in adults EKPG recommendation January 2016 April 2021

Substance dependence

Recommendation Approval date Review date
Public Health services commissioned by KCC - Stop Smoking. Information for GP practices EKPG February 2018 February 2021

Headache and Migraine

Recommendation Approval date Review date
Management of Adults with Headaches and Migraines in Primary Care August 2022 August 2024